Trials / Recruiting
RecruitingNCT06464016
Complications in Pediatric Mechanical Circulatory Assistance: Evaluation of Infection Management.
Relapse of VAD Infections After Discontinuation of Anti-infective Therapies in Children.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 47 (estimated)
- Sponsor
- Claude Bernard University · Academic / Other
- Sex
- All
- Age
- 1 Day – 18 Years
- Healthy volunteers
- Not accepted
Summary
Heart failure is a major cause of mortality and morbidity in children. Heart transplantation can significantly improve the prognosis of patients with severe heart failure, but access is limited by a shortage of transplants. Long-term mechanical circulatory support is a major advance in the management of heart failure and can provide haemodynamic support while awaiting myocardial recovery or heart transplantation. The Berlin Heart (BH) EXCOR is the only long-term support system available for children. Despite technical and medical advances in circulatory support, infection is a common complication and a major cause of morbidity and mortality in patients on BH. There are few studies on the management of infection with mechanical support. Current ISHLT (International Society for Heart and Lung Transplantation) recommendations are based on expert opinion and observational studies. Some experts recommend anti-infective therapy until transplantation for specific support infections or for support-associated infections with persistent bacteraemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ventricular Assist Device with Berlin Heart EXCOR | The Berlin Heart® EXCOR is a type of "artificial heart" pump that pulls blood from the ventricle and then sends that blood to the aorta or pulmonary trunc, thereby taking away extra work from the native heart. The device, which comes in several sizes, is not totally implanted inside the body. |
Timeline
- Start date
- 2023-07-04
- Primary completion
- 2025-10-01
- Completion
- 2025-11-01
- First posted
- 2024-06-18
- Last updated
- 2025-01-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06464016. Inclusion in this directory is not an endorsement.